Members

Minnetronix Neuro was born out of more than two decades of deep experience and expertise in medical technology and medical device development. With a focus on Neurocritical Care, Minnetronix Neuro is applying more than two decades of knowledge and expertise to build a portfolio of solutions to meet the needs of the Neuro ICU and unmet needs treating diseases of the brain.
Minnetronix Neuro is part of Minnetronix, Inc., a medical technology and innovation company founded in 1996 and based in Saint Paul, Minnesota. With over 300 employees and a successful history in device development and manufacturing, the company creates new technologies and therapies that solve unmet needs for patients and medical device companies. The company offers multiple pathways to create value, including intellectual property generation and new business models. Minnetronix Neuro is committed to quality and constant innovation, in order to become the total solutions company preventing secondary injury and enhancing healing in Neurocritical Care patients.
Minnetronix is FDA Registered and ISO 13485 Certified.

Duke University Medical Center/Duke Neurosurgery

Duke University Medical Center is one of the premier academic medical centers in the United States. Dr. Nandan Lad, Associate Professor of Neurosurgery at Duke, leads the Consortium’s efforts to advance Neurapheresis Therapy into human clinical research, and ultimately into the clinic for multiple indications. Duke Neurosurgery maintains an active service with 25 clinical neurosurgeons and a full team of advanced practice providers to meet the needs of adult and pediatric patients in need of neurosurgical care. In keeping with the vision of Duke Health, they are dedicated to the trifold mission of advancing patient care, physician training, and groundbreaking research. The Duke neurosurgical service is committed to the quest for the best possible treatment of diseases that affect the nervous system. Working as a team with several other medical specialties, they advise the patient as to the appropriate options for diagnosis and treatment for their conditions.
Together, Minnetronix Neuro and Duke University Medical Center are committed to providing compassionate care and to shepherding the most promising treatments from the laboratory to the clinic for previously incurable conditions.

Neurophysiological Imaging and Modeling Laboratory (NIML)

The Neurophysiological Imaging and Modeling Laboratory (NIML) at The University of Idaho Department of Biological Engineering is led by Bryn Martin. We conduct clinical translational research to investigate the pathophysiology of central nervous system (CNS) disorders and develop related medical technologies. The mission of the NIML is to become an internationally recognized leader in the study of the cerebrospinal fluid (CSF) system in relation to neurological disorders and to contribute to the advancement of CSF related technologies through active transfer of our know-how to the clinic and to the medical technology sector. Our multidisciplinary team and collaborators includes neurosurgeons, neurologists, neuroradiologists, engineers, artists, biologists and medical device manufacturers.

Tisch MS Research Center of New York

The Tisch Multiple Sclerosis Research Center of New York (Tisch MSRCNY) was formally launched in 2006 and is the largest independent MS center in the world. The research center conducts groundbreaking investigations into the cause of MS, biomarker research aimed at developing precise diagnostic and predictive tools to bring the disease under the control of treating neurologists, and novel regenerative strategies for repairing the damage done by the disease in patients who are unresponsive to standard treatments. In 2012 with the generous assistance of our benefactors we initiated a further expansion to an area encompassing approximately 80,000 square feet to house the latest in research equipment and technology designed to accelerate the pace of MS research and treatment. The close relationship of the research center and the clinical practice, International Multiple Sclerosis Management Practice (IMSMP), speeds the translation of basic science into clinical practice and helps to test new treatments for MS. Our unity of purpose, and an ease of communication between the clinical and research staff of over 80 individuals creates a unique environment that accelerates the pace of scientific discovery and advancement at minimum cost and with minimal bureaucratic constraints.

Penn Neuroscience Center

The Penn Neurosciences Center, located at the Perelman Center for Advanced Medicine at the University of Pennsylvania in Philadelphia, provides patients with access to doctors, diagnostic imaging and treatment options in one central, convenient location. Penn Neurosciences is one of the leading neuroscience programs in the nation. Patients benefit from not only having access to experts in the field of neurological care, but also to cutting edge research – research that translates into clinical practice, allowing Penn to provide patients with the latest, safest and most advanced treatment options. By embracing new technology and seeking the best outcomes possible, Penn is the leader the clinical advancement of neurological conditions. The Neuroscience Center includes 35 shared exam rooms 14 consultation rooms, four rooms with specialized ophthalmology equipment, 10 EEG/EMG rooms, a radiology reading room and space for research coordination and clinical trial enrollment.
Contact NRC for more information about our programs or participation inquiries, contact us.
CAUTION – Investigational Device, limited by Federal Law to Investigational Use.
Minnetronix is a registered trademark, and Neurapheresis is a trademark of Minnetronix, Inc.
©Minnetronix, Inc. All rights reserved.